Open-label duloxetine treatment of major depression in patients age ≥ 65

被引:0
|
作者
Kennedy, JS [1 ]
Mallinckrodt, CH [1 ]
Wohlreich, MM [1 ]
Raskin, J [1 ]
Goldstein, DJ [1 ]
Tran, PV [1 ]
Detke, M [1 ]
机构
[1] Lilly Corp Ctr, Indianapolis, IN USA
关键词
D O I
暂无
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
引用
收藏
页码:1069 / 1069
页数:1
相关论文
共 50 条
  • [1] Open-label duloxetine treatment of major depression in patients age ≥65.
    Wohlreich, MM
    Kennedy, JS
    Mallinckrodt, C
    Raskin, J
    Tran, PV
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (04) : S129 - S130
  • [2] Open-label duloxetine treatment of major depression:: Comparisons between elderly (age >65) and younger (age <65) patients
    Hay, D
    Wohlreich, M
    Mallinckrodt, C
    Watkin, J
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 241 - 241
  • [3] Open-label duloxetine treatment of major depression:: Comparison of efficacy and safety in elderly (age >/=65) and younger patients
    Wohlreich, M
    Hay, D
    Mallinckrodt, C
    Watkin, J
    GERONTOLOGIST, 2003, 43 : 168 - 168
  • [4] Open-label duloxetine treatment of major depression: Comparison of efficacy and safety in elderly and younger patients
    Wohlreich, MM
    Mallinckrodt, C
    Watkin, J
    Hay, D
    PSYCHOSOMATICS, 2004, 45 (02) : 163 - 164
  • [5] An Open-Label Safety and Pharmacokinetics Study of Duloxetine in Pediatric Patients with Major Depression
    Prakash, Apurva
    Lobo, Evelyn
    Kratochvil, Christopher J.
    Tamura, Roy N.
    Pangallo, Beth A.
    Bullok, Kristin E.
    Quinlan, Tonya
    Emslie, Graham J.
    March, John S.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2012, 22 (01) : 48 - 55
  • [6] Clinical and Demographic Predictors of Improvement during Duloxetine Treatment in Patients with Major Depression An Open-Label Study
    Di Nasso, Elena
    Chiesa, Alberto
    Serretti, Alessandro
    De Ronchi, Diana
    Mencacci, Claudio
    CLINICAL DRUG INVESTIGATION, 2011, 31 (06) : 385 - 405
  • [7] Duloxetine in the treatment of major depressive disorder: an open-label study
    Hudson, James I.
    Perahia, David G.
    Gilaberte, Inmaculada
    Wang, Fujun
    Watkin, John G.
    Detke, Michael J.
    BMC PSYCHIATRY, 2007, 7 (1) : 43
  • [8] Duloxetine in the treatment of major depressive disorder: an open-label study
    James I Hudson
    David G Perahia
    Inmaculada Gilaberte
    Fujun Wang
    John G Watkin
    Michael J Detke
    BMC Psychiatry, 7
  • [9] Duloxetine treatment of dysthymia and double depression: an open-label trial
    Koran, Lorrin M.
    Aboujaoude, Elias N.
    Gamel, Nona N.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (05) : 761 - 765
  • [10] Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: An open-label study
    Wohlreich M.M.
    Mallinckrodt C.H.
    Watkin J.G.
    Hay D.P.
    BMC Geriatrics, 4 (1)